Literature DB >> 16864677

Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1.

Fumito Okada1, Yumiko Ando, Sachie Yoshitake, Shinji Yotsumoto, Shunro Matsumoto, Masaki Wakisaka, Toru Maeda, Hiromu Mori.   

Abstract

PURPOSE: To retrospectively evaluate pulmonary computed tomographic (CT) findings in human T-lymphotropic virus type 1 (HTLV-1) carriers, who were characterized by means of polyclonal integration of proviral DNA.
MATERIALS AND METHODS: Institutional review board approval was obtained, and informed consent was waived. Chest CT scans obtained between January 1996 and October 2004 in 320 (154 men, 166 women; age range, 31-86 years; mean, 64 years) patients with HTLV-1 were retrospectively evaluated by three chest radiologists. Parenchymal abnormalities (ground-glass opacity, consolidation, centrilobular nodules, thickening of bronchovascular bundles, interlobular septal thickening, and bronchiectasis) were evaluated, along with enlarged lymph nodes and pleural effusion. In 58 patients who underwent surgical biopsy or transbronchial biopsy, comparison of CT images with the actual specimens was performed by a pathologist and three chest radiologists.
RESULTS: On CT scans, abnormal findings were seen in 98 (30.1%) patients and consisted of centrilobular nodules (n = 95), thickening of bronchovascular bundles (n = 55), ground-glass opacity (n = 51), bronchiectasis (n = 50), interlobular septal thickening (n = 28), and consolidation (n = 5). These abnormalities were predominantly seen in the peripheral lung parenchyma (n = 70). Pathologically, these findings corresponded to lymphocytic infiltration along respiratory bronchioles and bronchovascular bundles. Pleural effusion and enlarged lymph nodes were found in two and five patients, respectively.
CONCLUSION: CT findings in patients with HTLV-1 consisted mainly of centrilobular nodules, ground-glass opacity, and thickening of the bronchovascular bundles in the peripheral lung. These CT findings are considered suggestive of thoracic involvement in patients with HTLV-1. RSNA, 2006

Entities:  

Mesh:

Year:  2006        PMID: 16864677     DOI: 10.1148/radiol.2402050886

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

3.  In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.

Authors:  Silva Hilburn; Aileen Rowan; Maria-Antonietta Demontis; Aidan MacNamara; Becca Asquith; Charles R M Bangham; Graham P Taylor
Journal:  J Infect Dis       Date:  2011-01-05       Impact factor: 5.226

4.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

5.  Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Authors:  Lloyd Einsiedel; Tim Spelman; Emma Goeman; Olivier Cassar; Mick Arundell; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

6.  High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease.

Authors:  Shohreh Honarbakhsh; Graham P Taylor
Journal:  BMC Infect Dis       Date:  2015-07-06       Impact factor: 3.090

7.  A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.

Authors:  Mattia Vicario; Adriana Mattiolo; Barbara Montini; Maria Assunta Piano; Ilaria Cavallari; Alberto Amadori; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  Front Microbiol       Date:  2018-06-13       Impact factor: 5.640

8.  CT Chest and pulmonary functional changes in patients with HTLV-associated myelopathy in the Eastern Brazilian Amazon.

Authors:  Luiz Fábio Magno Falcão; Aline Semblano Carreira Falcão; Rita Catarina Medeiros Sousa; Waldônio de Brito Vieira; Robson Tadachi Moraes de Oliveira; Valéria Marques Ferreira Normando; George Alberto da Silva Dias; Marcio Clementino de Souza Santos; Rodrigo Santiago Barbosa Rocha; Gilberto Toshimitsu Yoshikawa; Roberta Vilela Lopes Koyama; Satomi Fujihara; Víctor Augusto Cavaleiro Corrêa; Hellen Thais Fuzii; Juarez Antônio Simões Quaresma
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

9.  Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.

Authors:  Lloyd Einsiedel; Hai Pham; Kim Wilson; Rebecca Walley; Jocelyn Turpin; Charles Bangham; Antoine Gessain; Richard J Woodman
Journal:  PLoS Negl Trop Dis       Date:  2018-03-12

Review 10.  Human T Lymphotropic Virus and Pulmonary Diseases.

Authors:  Apio R N Dias; Luiz F M Falcão; Aline S C Falcão; Valéria M F Normando; Juarez A S Quaresma
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.